Skip to content

The Role of SGLT-2 Inhibitors in Chronic Kidney Disease: Clinical Applications, Precautions, and Future Directions

Introduction: A Paradigm Shift in Chronic Kidney Disease Management Chronic Kidney Disease (CKD) is a progressive condition characterized by the gradual loss of kidney function due to various causes, including diabetes, hypertension, and glomerulonephritis. CKD… The Role of SGLT-2 Inhibitors in Chronic Kidney Disease: Clinical Applications, Precautions, and Future Directions

Comprehensive Review of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Monotherapy vs. Combination Therapy in CKD and Cardiovascular Disease

Introduction Sodium-glucose co-transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as crucial pharmacological agents in managing type 2 diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD). These drug classes provide… Comprehensive Review of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Monotherapy vs. Combination Therapy in CKD and Cardiovascular Disease